IPO registrations (S-1, F-1) · Registrants
Onconetix, Inc.
- SEC CIK
- 1782107 · filings on EDGAR ↗
- Former names
- Blue Water Biotech, Inc. (2023–2023); Blue Water Vaccines Inc. (2019–2023)
- Registration
- Form S-1, first filed 2021-10-08, last 2026-08-31; 12 initial registrations, 18 amendments
- Outcome
- Final prospectus filed 2022-02-23; declared effective 2022-02-11
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 201 E. FIFTH STREET, SUITE 1900, Cincinnati, OH 45202
- Ticker
- ONCO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Onconetix, Inc. on the corporate pages
On this site
- Business registration: ONCONETIX, INC. Fuzzy (name and state)
- Form D issuer: Onconetix, Inc. EXACT (CIK (EXACT))
- SEC filer: Blue Water Biotech, Inc. EXACT (CIK (EXACT))
Filings 48
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-10-08 | S-1 | S-1 (registration) | Blue Water Vaccines Inc. | 0001213900-21-052037 ↗ |
| 2021-11-05 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-21-056861 ↗ |
| 2021-11-29 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-21-062397 ↗ |
| 2021-12-13 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-21-065028 ↗ |
| 2021-12-29 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-21-067785 ↗ |
| 2022-01-06 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-22-000991 ↗ |
| 2022-02-08 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-22-005856 ↗ |
| 2022-02-11 | EFFECT | EFFECT (declared effective) | Blue Water Vaccines Inc. | 9999999995-22-000414 ↗ |
| 2022-02-23 | 424B4 | 424B4 (final prospectus) | Blue Water Vaccines Inc. | 0001213900-22-008760 ↗ |
| 2022-05-03 | S-1 | S-1 (registration) | Blue Water Vaccines Inc. | 0001213900-22-023717 ↗ |
| 2022-05-19 | S-1/A | S-1/A (amendment) | Blue Water Vaccines Inc. | 0001213900-22-028272 ↗ |
| 2022-05-20 | EFFECT | EFFECT (declared effective) | Blue Water Vaccines Inc. | 9999999995-22-001565 ↗ |
| 2022-08-29 | S-1 | S-1 (registration) | Blue Water Vaccines Inc. | 0001213900-22-051830 ↗ |
| 2022-09-19 | EFFECT | EFFECT (declared effective) | Blue Water Vaccines Inc. | 9999999995-22-002749 ↗ |
| 2022-09-20 | 424B4 | 424B4 (final prospectus) | Blue Water Vaccines Inc. | 0001213900-22-057418 ↗ |
| 2023-03-16 | EFFECT | EFFECT (declared effective) | Blue Water Vaccines Inc. | 9999999995-23-000596 ↗ |
| 2023-05-04 | EFFECT | EFFECT (declared effective) | Blue Water Biotech, Inc. | 9999999995-23-001281 ↗ |
| 2024-02-14 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-24-014137 ↗ |
| 2024-04-26 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-036738 ↗ |
| 2024-06-05 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-049815 ↗ |
| 2024-06-25 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-055360 ↗ |
| 2024-07-01 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-24-002031 ↗ |
| 2024-07-03 | 424B4 | 424B4 (final prospectus) | Onconetix, Inc. | 0001213900-24-059033 ↗ |
| 2024-11-01 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-24-093575 ↗ |
| 2024-11-01 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-24-093577 ↗ |
| 2024-11-12 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-096410 ↗ |
| 2024-11-12 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-096598 ↗ |
| 2024-11-12 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-24-003465 ↗ |
| 2024-11-15 | 424B4 | 424B4 (final prospectus) | Onconetix, Inc. | 0001213900-24-098814 ↗ |
| 2024-12-10 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-107464 ↗ |
| 2024-12-11 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-24-107952 ↗ |
| 2024-12-12 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-24-003761 ↗ |
| 2025-01-27 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-25-006626 ↗ |
| 2025-02-07 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-25-011380 ↗ |
| 2025-02-11 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-25-000394 ↗ |
| 2025-10-16 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-25-099298 ↗ |
| 2025-11-04 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-25-106177 ↗ |
| 2025-12-22 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-25-124018 ↗ |
| 2025-12-23 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-25-003904 ↗ |
| 2026-04-28 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-26-048535 ↗ |
| 2026-05-07 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-26-053255 ↗ |
| 2026-05-07 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-26-001545 ↗ |
| 2026-05-11 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-26-001568 ↗ |
| 2026-06-09 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-26-066400 ↗ |
| 2026-06-16 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-26-002024 ↗ |
| 2026-08-12 | S-1 | S-1 (registration) | Onconetix, Inc. | 0001213900-26-087986 ↗ |
| 2026-08-31 | S-1/A | S-1/A (amendment) | Onconetix, Inc. | 0001213900-26-095703 ↗ |
| 2026-09-03 | EFFECT | EFFECT (declared effective) | Onconetix, Inc. | 9999999995-26-002880 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Cincinnati Cornerstone Capital LLC | Other; TenPercentOwner | 5 | 2022–2023 | ||
| Cincinnati Cornerstone Investors BWV I, LLC | TenPercentOwner | 5 | 2022–2023 | ||
| Garfield Jon | Director; Officer | CFO; Chief Financial Officer | 3 | 2022–2023 | |
| Henderson Erin | Officer | Chief Business Officer | 4 | 2022–2023 | |
| Hernandez Joseph | Director,Officer,TenPercentOwner; Officer,TenPercentOwner | CEO | 4 | 2022–2023 | |
| Murphy Kimberly M | Director | 2 | 2022 | ||
| Rice John McCune Jr. | Director | 1 | 2022 | ||
| Shaw Allan | Director | 3 | 2022 | ||
| Venerable Michael | Director | 2 | 2022 | ||
| SAPIRSTEIN JAMES | Director | 4 | 2022–2024 | ||
| Tarsh Simon | Director | 5 | 2022–2025 | ||
| Jeremic Vuk | Director | 3 | 2022–2023 | ||
| Ramdeen Timothy R. | Director | 5 | 2023–2025 | ||
| CAMPBELL NEIL J | Director,Officer | Chief Executive Officer | 1 | 2023 | |
| Harmon Bruce | Officer | Chief Financial Officer | 1 | 2023 | |
| Bruhlmann Christian | Officer | Chief Strategy Officer | 3 | 2023–2025 | |
| Schiess Ralph | Officer | Chief Science Officer; Interim CEO & CSO; Interim CEO, CSO | 3 | 2024–2025 | |
| Meier Thomas | Director | 3 | 2024–2025 | ||
| SINGH AJIT | Director | 3 | 2024 | ||
| FEDASZ KARINA M | Officer | Interim CFO | 1 | 2024 | |
| Altos Venture AG | TenPercentOwner | 3 | 2024–2025 | ||
| Oakley Andrew John | Director | 3 | 2025 | ||
| Romano Sarah | Director | 1 | 2025 | ||
| DORF SAMMY | Director | 1 | 2026 | ||
| White David Allan | Officer | Chief Executive Officer | 1 | 2026 | |
| HRT FINANCIAL LP | TenPercentOwner | 4 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-10-07 | Onconetix, Inc. | Biotechnology | $12,977,670 | $12,977,670 | 11 | 1 |
| 2024-10-17 | Onconetix, Inc. | Biotechnology | $2,000,000 | $2,000,000 | 5 | 1 |
| 2019-07-15 | Blue Water Vaccines Inc. | Biotechnology | $6,979,980 | $6,979,980 | 5 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.